Skip to main content
Screener/Healthcare/Biotechnology

PHAT — Phathom Pharmaceuticals, Inc.

NASDAQ
$5.71-0.50 (-8.04%)
Small CapUnder $10HealthcareFastest Growing
$5.01
$18.31
$5.59
$6.32
EPS (TTM)$-2.12
P/E Ratio-3.73
Dividend Yield—
Market Cap$508.1M
Volume1.14M
Prev Close$6.22
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$58.3M$0$-0.3779.4%0.0%
Q4 '25$57.6M-$21.1M$-0.2986.7%-36.7%
Q3 '25$49.5M-$30.0M$-0.4187.5%-60.5%
Q2 '25$39.5M-$75.8M$-1.0587.2%-191.9%
Q1 '25$28.5M-$94.3M$-1.3186.9%-330.7%
Q4 '24$29.7M-$74.5M$-1.0587.1%-251.0%
Q3 '24$16.4M-$85.6M$-1.3285.6%-523.3%
Q2 '24$7.3M-$91.4M$-1.5681.2%-1248.6%
Get Your Daily Market Recap